1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Jordan Pharmaceuticals and Healthcare Report Q3 2016

Jordan Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 92 pages

Includes 3 FREE quarterly updates

BMI View: Jordan's pharmaceutical and healthcare markets have enormous potential to develop intoattractive investment prospects for multinational pharmaceutical companies. The country's domesticpharmaceutical industry will continue to strengthen as consolidation and merger activity increases in thecountry. Partnership and cooperation will most likely take the form of licensing and regionalrepresentation, with the latter potentially giving Jordan 'production hub' status in the region. Thegovernment remains committed to healthcare modernisation and expansion, and in order to address thecountry's leading disease burdens such as diabetes and cancer, it is actively encouraging the rollout ofawareness campaigns and national programmes of strategy.

Headline Expenditure Projections

- Pharmaceuticals: JOD683mn (USD962mn) in 2015 to JOD727mn (USD1.02bn) by 2016; +6.4% inlocal currency terms and US dollar terms. Forecast unchanged from Q216.

- Healthcare: JOD2.03bn (USD2.85bn) in 2015 to JOD2.17bn (USD3.05bn) by 2016; +6.9 in localcurrency terms and US dollar terms. Forecast in line with Q216.

Table Of Contents

Jordan Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Jordan 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Jordan 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Jordan 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Jordan 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Jordan 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Jordan 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Jordan 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Jordan 2014-2020) 28
Industry Risk/Reward Index 29
Middle East and Africa Risk/Reward Index - Q3 2016 29
Jordan Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 40
Intellectual Property Issues 41
Pricing And Reimbursement Regime 43
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Jordan 2010-2015) 52
Table: Healthcare Personnel (Jordan 2010-2015) 52
Table: Healthcare Activity (Jordan 2010-2015) 53
Research and Development 53
Clinical Trials 54
Epidemiology 56
Competitive Landscape 59
Research-Based Industry 59
Table: Multinational Market Activity 62
Generic Drugmakers 63
Pharmaceutical Distribution 63
Pharmaceutical Retail Sector 64
Company Profile 65
Dar al-Dawa 65
Hikma Pharmaceuticals 68
Jordanian Pharmaceutical Manufacturing Company (JPM) 73
Pharma International Company 76
United Pharmaceutical Manufacturers 78
Demographic Forecast 81
Jordan Demographic Forecast 81
Table: Population Headline Indicators (Jordan 1990-2025) 82
Table: Key Population Ratios (Jordan 1990-2025) 82
Table: Urban/Rural Population and Life Expectancy (Jordan 1990-2025) 83
Table: Population By Age Group (Jordan 1990-2025) 83
Table: Population By Age Group % (Jordan 1990-2025) 84
Glossary 86
Methodology 88
Pharmaceutical Expenditure Forecast Model 88
Healthcare Expenditure Forecast Model 88
Notes On Methodology 89
Risk/Reward Index Methodology 90
Index Overview 91
Table: Pharmaceutical Risk/Reward Index Indicators 91
Indicator Weightings 92

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.